BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 31741141)

  • 1. PRDM14 promotes malignant phenotype and correlates with poor prognosis in colorectal cancer.
    Igarashi H; Taniguchi H; Nosho K; Ishigami K; Koide H; Mitsuhashi K; Okita K; Takemasa I; Imai K; Nakase H
    Clin Transl Oncol; 2020 Jul; 22(7):1126-1137. PubMed ID: 31741141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SNHG4-mediated PTEN destabilization confers oxaliplatin resistance in colorectal cancer cells by inhibiting ferroptosis.
    Li SQ; Xu WT; Yin YX; Wei HT; Li KZ; Xie MZ; Lv F; Xie LY; Hu BL
    Apoptosis; 2024 Jun; 29(5-6):835-848. PubMed ID: 38573492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemosensitivity analysis and study of gene resistance on tumors and cancer stem cell isolates from patients with colorectal cancer.
    Garza-Treviño EN; Martínez-Rodríguez HG; Delgado-González P; Solís-Coronado O; Ortíz-Lopez R; Soto-Domínguez A; Treviño VM; Padilla-Rivas GR; Islas-Cisneros JF; Quiroz-Reyes AG; Said-Fernández SL
    Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FXYD6 Regulates Chemosensitivity by Mediating the Expression of Na+/K+-ATPase
    Luo W; Liu Q; Chen X; Liu H; Quan B; Lu J; Zhang K; Wang X
    Biomed Res Int; 2021; 2021():9986376. PubMed ID: 34212047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIAA1549 promotes the development and chemoresistance of colorectal cancer by upregulating ERCC2.
    Ye F; Xie Y; Lin M; Liu Y; Fang Y; Chen K; Zhang Y; Ding Y
    Mol Cell Biochem; 2024 Mar; 479(3):629-642. PubMed ID: 37140813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical role of PRDM14 in human primordial germ cell fate revealed by inducible degrons.
    Sybirna A; Tang WWC; Pierson Smela M; Dietmann S; Gruhn WH; Brosh R; Surani MA
    Nat Commun; 2020 Mar; 11(1):1282. PubMed ID: 32152282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YAP1 and PRDM14 converge to promote cell survival and tumorigenesis.
    Kim M; Ly SH; Xie Y; Duronio GN; Ford-Roshon D; Hwang JH; Sulahian R; Rennhack JP; So J; Gjoerup O; Talamas JA; Grandclaudon M; Long HW; Doench JG; Sethi NS; Giannakis M; Hahn WC
    Dev Cell; 2022 Jan; 57(2):212-227.e8. PubMed ID: 34990589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kruppel-like factor 5 enhances proliferation, lipid droplet formation and oxaliplatin resistance in colorectal cancer by promoting fatty acid binding protein 6 transcription.
    Zuo Q; Xu Q; Li Z; Luo D; Peng H; Duan Z
    Anticancer Drugs; 2023 Nov; 34(10):1171-1182. PubMed ID: 37067981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TMPRSS13 promotes cell survival, invasion, and resistance to drug-induced apoptosis in colorectal cancer.
    Varela FA; Foust VL; Hyland TE; Sala-Hamrick KE; Mackinder JR; Martin CE; Murray AS; Todi SV; List K
    Sci Rep; 2020 Aug; 10(1):13896. PubMed ID: 32807808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMO2/3 promotes the progression and oxaliplatin resistance of colorectal cancer through facilitating the SUMOylation at Ku80-K307.
    Feng D; He J; Yuan M; Chen Q; Zeng X; Zhou Q; Wu J; Han B
    Biofactors; 2023; 49(6):1158-1173. PubMed ID: 37338025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of protein kinase C increases Prdm14 level to promote self-renewal of embryonic stem cells through reducing Suv39h-induced H3K9 methylation.
    Ji J; Cao J; Chen P; Huang R; Ye SD
    J Biol Chem; 2024 Mar; 300(3):105714. PubMed ID: 38309502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Apurinic/Apyrimidinic Endonuclease 1 in Colorectal Cancer and its Relation to Tumor Progression and Prognosis.
    Hong JY; Oh HH; Park SY; Park YL; Cho SB; Joo YE
    In Vivo; 2023; 37(5):2070-2077. PubMed ID: 37652525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the RBMS1/PRNP axis improves ferroptosis resistance-mediated oxaliplatin chemoresistance in colorectal cancer.
    Xu Y; Hao J; Chen Q; Qin Y; Qin H; Ren S; Sun C; Zhu Y; Shao B; Zhang J; Wang H
    Mol Carcinog; 2024 Feb; 63(2):224-237. PubMed ID: 37861356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive assessment and therapeutic monitoring of drug-resistant colorectal cancer by MR molecular imaging of extradomain-B fibronectin.
    Vaidya A; Ayat N; Buford M; Wang H; Shankardass A; Zhao Y; Gilmore H; Wang Z; Lu ZR
    Theranostics; 2020; 10(24):11127-11143. PubMed ID: 33042274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Claudin-1 interacts with EPHA2 to promote cancer stemness and chemoresistance in colorectal cancer.
    Primeaux M; Liu X; Gowrikumar S; Fatima I; Fisher KW; Bastola D; Vecchio AJ; Singh AB; Dhawan P
    Cancer Lett; 2023 Nov; 579():216479. PubMed ID: 37924938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mouse model for inducible overexpression of Prdm14 results in rapid-onset and highly penetrant T-cell acute lymphoblastic leukemia (T-ALL).
    Carofino BL; Ayanga B; Justice MJ
    Dis Model Mech; 2013 Nov; 6(6):1494-506. PubMed ID: 24046360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronin 2A (CRN5) expression is associated with colorectal adenoma-adenocarcinoma sequence and oncogenic signalling.
    Rastetter RH; Blömacher M; Drebber U; Marko M; Behrens J; Solga R; Hojeili S; Bhattacharya K; Wunderlich CM; Wunderlich FT; Odenthal M; Ziemann A; Eichinger L; Clemen CS
    BMC Cancer; 2015 Sep; 15():638. PubMed ID: 26373535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRDM14 extinction enables the initiation of trophoblast stem cell formation.
    Xu C; Zhao W; Peng L; Yin T; Guo J; Li Y; Liu L; Yang J; Xu C; Du M
    Cell Mol Life Sci; 2024 May; 81(1):208. PubMed ID: 38710919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ECA39 is a novel distant metastasis-related biomarker in colorectal cancer.
    Yoshikawa R; Yanagi H; Shen CS; Fujiwara Y; Noda M; Yagyu T; Gega M; Oshima T; Yamamura T; Okamura H; Nakano Y; Morinaga T; Hashimoto-Tamaoki T
    World J Gastroenterol; 2006 Sep; 12(36):5884-9. PubMed ID: 17007058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IMP1/IGF2BP1 in human colorectal cancer extracellular vesicles.
    Kuhn M; Zhang Y; Favate J; Morita M; Blucher A; Das S; Liang S; Preet R; Parham LR; Williams KN; Molugu S; Armstrong RJ; Zhang W; Yang J; Hamilton KE; Dixon DA; Mills G; Morgan TK; Shah P; Andres SF
    Am J Physiol Gastrointest Liver Physiol; 2022 Dec; 323(6):G571-G585. PubMed ID: 36194131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.